Meeting Banner
Abstract #3592

QSM Source Separation Detects Treatment Effect of Ocrelizumab on Multiple Sclerosis Lesion Myelin: A Longitudinal Study

Mert Sisman1,2, Kimberly Markowitz3, Ha M. Luu2, Hannah Schwartz3, Iliana Pliska-Bloch3, Pascal Spincemaille2, Ilhami Kovanlikaya2, Sandra M. Hurtado Rua4, Susan A. Gauthier3, Yi Wang2,5, and Thanh D. Nguyen2
1Electrical and Computer Engineering, Cornell University, New York, NY, United States, 2Department of Radiology, Weill Cornell Medicine, New York, NY, United States, 3Department of Neurology, Weill Cornell Medicine, New York, NY, United States, 4Department of Mathematics and Statistics, Cleveland State University, Cleveland, OH, United States, 5Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY, United States

Synopsis

Keywords: Multiple Sclerosis, Multiple Sclerosis, Myelin, iron

Motivation: Noninvasive tools for monitoring the changes in tissue during treatment is an important clinical need. In Multiple Sclerosis (MS), estimation of iron and myelin content is essential.

Goal(s): This study aims to demonstrate the potential of a newly developed technique for myelin and iron change detection during treatment from gradient-echo data.

Approach: Data from 29 MS patient were retrospectively collected over a period of time that covers the treatment start and all data were processed to estimate iron and myelin biomarkers.

Results: Statistical analyses showed that the Ocrelizumab treatment caused overall iron decrease and remyelination.

Impact: Treatment efforts in Multiple Sclerosis includes medications that suppress acute inflammation. Therefore, the noninvasive quantification of the effect of treatment on the iron change and remyelination carries significant importance. Here, a novel gradient-echo based approach is tested for this purpose.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.

Keywords